vs

Side-by-side financial comparison of Castellum, Inc. (CTM) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

Castellum, Inc. is the larger business by last-quarter revenue ($12.6M vs $8.7M, roughly 1.4× Wave Life Sciences Ltd.). Castellum, Inc. runs the higher net margin — -10.5% vs -580.2%, a 569.6% gap on every dollar of revenue. On growth, Castellum, Inc. posted the faster year-over-year revenue change (21.9% vs -55.8%). Over the past eight quarters, Castellum, Inc.'s revenue compounded faster (5.3% CAGR vs -18.0%).

Castellum, Inc. is a U.S.-based cybersecurity and information technology services provider. It caters to government defense agencies, public sector entities, and commercial enterprise clients, offering threat detection, data protection, cloud security, and managed IT solutions to help organizations mitigate cyber risks and safeguard critical digital infrastructure.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

CTM vs WVE — Head-to-Head

Bigger by revenue
CTM
CTM
1.4× larger
CTM
$12.6M
$8.7M
WVE
Growing faster (revenue YoY)
CTM
CTM
+77.8% gap
CTM
21.9%
-55.8%
WVE
Higher net margin
CTM
CTM
569.6% more per $
CTM
-10.5%
-580.2%
WVE
Faster 2-yr revenue CAGR
CTM
CTM
Annualised
CTM
5.3%
-18.0%
WVE

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CTM
CTM
WVE
WVE
Revenue
$12.6M
$8.7M
Net Profit
$-1.3M
$-50.5M
Gross Margin
33.9%
Operating Margin
-11.1%
-606.5%
Net Margin
-10.5%
-580.2%
Revenue YoY
21.9%
-55.8%
Net Profit YoY
51.8%
-53.3%
EPS (diluted)
$-0.02
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTM
CTM
WVE
WVE
Q4 25
$12.6M
Q3 25
$14.6M
Q2 25
$14.0M
$8.7M
Q1 25
$11.7M
$9.2M
Q4 24
$10.3M
Q3 24
$11.6M
Q2 24
$11.5M
$19.7M
Q1 24
$11.3M
$12.5M
Net Profit
CTM
CTM
WVE
WVE
Q4 25
$-1.3M
Q3 25
$415.4K
Q2 25
$-322.1K
$-50.5M
Q1 25
$-1.2M
$-46.9M
Q4 24
$-2.7M
Q3 24
$-1.3M
Q2 24
$-1.8M
$-32.9M
Q1 24
$-4.1M
$-31.6M
Gross Margin
CTM
CTM
WVE
WVE
Q4 25
33.9%
Q3 25
37.6%
Q2 25
36.1%
Q1 25
39.0%
Q4 24
40.0%
Q3 24
42.7%
Q2 24
40.6%
Q1 24
39.8%
Operating Margin
CTM
CTM
WVE
WVE
Q4 25
-11.1%
Q3 25
3.0%
Q2 25
-2.7%
-606.5%
Q1 25
-12.7%
-542.8%
Q4 24
-15.7%
Q3 24
-11.9%
Q2 24
-13.6%
-177.7%
Q1 24
-23.6%
-274.8%
Net Margin
CTM
CTM
WVE
WVE
Q4 25
-10.5%
Q3 25
2.8%
Q2 25
-2.3%
-580.2%
Q1 25
-10.0%
-510.9%
Q4 24
-26.6%
Q3 24
-11.0%
Q2 24
-16.0%
-167.2%
Q1 24
-36.3%
-251.7%
EPS (diluted)
CTM
CTM
WVE
WVE
Q4 25
$-0.02
Q3 25
$0.00
Q2 25
$0.00
$-0.31
Q1 25
$-0.01
$-0.29
Q4 24
$-0.05
Q3 24
$-0.02
Q2 24
$-0.03
$-0.25
Q1 24
$-0.08
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTM
CTM
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$208.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.8M
$139.3M
Total Assets
$41.9M
$252.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTM
CTM
WVE
WVE
Q4 25
Q3 25
Q2 25
$208.5M
Q1 25
$243.1M
Q4 24
Q3 24
Q2 24
$154.0M
Q1 24
$180.9M
Total Debt
CTM
CTM
WVE
WVE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$8.0M
Q3 24
$8.3M
Q2 24
$8.7M
Q1 24
$9.0M
Stockholders' Equity
CTM
CTM
WVE
WVE
Q4 25
$35.8M
Q3 25
$36.7M
Q2 25
$31.8M
$139.3M
Q1 25
$26.1M
$171.8M
Q4 24
$20.2M
Q3 24
$12.0M
Q2 24
$12.1M
$-3.5M
Q1 24
$12.8M
$25.4M
Total Assets
CTM
CTM
WVE
WVE
Q4 25
$41.9M
Q3 25
$46.3M
Q2 25
$43.4M
$252.4M
Q1 25
$41.1M
$288.3M
Q4 24
$37.8M
Q3 24
$28.8M
Q2 24
$29.5M
$208.8M
Q1 24
$30.5M
$235.3M
Debt / Equity
CTM
CTM
WVE
WVE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.40×
Q3 24
0.69×
Q2 24
0.72×
Q1 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTM
CTM
WVE
WVE
Operating Cash FlowLast quarter
$-661.7K
$-46.0M
Free Cash FlowOCF − Capex
$-46.3M
FCF MarginFCF / Revenue
-532.5%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTM
CTM
WVE
WVE
Q4 25
$-661.7K
Q3 25
$1.0M
Q2 25
$214.2K
$-46.0M
Q1 25
$-2.5M
$-63.0M
Q4 24
$-394.4K
Q3 24
$742.2K
Q2 24
$748.6K
$-27.5M
Q1 24
$23.7K
$-33.4M
Free Cash Flow
CTM
CTM
WVE
WVE
Q4 25
Q3 25
$957.0K
Q2 25
$-46.3M
Q1 25
$-63.2M
Q4 24
Q3 24
$738.9K
Q2 24
$-27.5M
Q1 24
$-33.8M
FCF Margin
CTM
CTM
WVE
WVE
Q4 25
Q3 25
6.5%
Q2 25
-532.5%
Q1 25
-688.9%
Q4 24
Q3 24
6.4%
Q2 24
-139.8%
Q1 24
-270.0%
Capex Intensity
CTM
CTM
WVE
WVE
Q4 25
Q3 25
0.3%
Q2 25
3.5%
Q1 25
1.8%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
0.3%
Q1 24
0.0%
3.3%
Cash Conversion
CTM
CTM
WVE
WVE
Q4 25
Q3 25
2.41×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons